Regulatory Compliance in Healthcare Industry

regulatory compliance in healthcare industry

What is Regulatory Compliance in Healthcare Industry? Regulatory compliance in the healthcare industry in India encompasses adherence to several laws, regulations, guidelines and specifications relevant to healthcare practices. It ensures that healthcare providers operate within the legal framework established by national and state authorities. This includes compliance with the Clinical Establishments Act, Medical Council of India regulations, and specific healthcare laws like the Drugs and Cosmetics Act, 1940. 

In the healthcare industry, compliance involves implementing policies and procedures to comply with regulatory requirements, safeguarding patient data, and maintaining high standards of care. Regulatory compliance in the healthcare industry is not just a legal requirement; it’s a fundamental aspect of maintaining quality care and protecting patient data. 

Regulatory Compliance in Healthcare Industry

Regulatory compliance in the healthcare industry is critical to operations, ensuring quality care and patient safety. In today’s dynamic healthcare landscape, maintaining regulatory compliance in healthcare is essential for businesses to uphold ethical standards, mitigate legal risks, and foster stakeholder trust. 

1. The Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 2020 

These are crucial pieces of legislation in India governing the manufacture, sale, distribution, and import of drugs and cosmetics. These regulations are essential for ensuring the safety, efficacy, and quality of pharmaceutical products and protecting public health.

  • The Drugs and Cosmetics Act, 1940 (D&C Act) mandates that anyone involved in the manufacturing, sale, distribution or stocking of drugs and cosmetics must hold a valid license. This ensures that only qualified and authorized individuals are allowed to engage in these activities.
  • The Rules introduce the concept of ‘New Cosmetics,’ defined as those containing novel ingredients not previously used anywhere or recognized for use in cosmetics. Importers of new cosmetics must seek approval from the Central Licensing Authority (CLSA) by submitting an application and complying with safety evaluation standards.
  • The Act raises concerns about the practice of telephonic authorization for selling prescription drugs, emphasizing the importance of in-person patient examination by RMPs as mandated by the Medical Council of India. 
  • The D&C Act also addresses the issue of counterfeit drugs, prohibiting their manufacturing, sale, distribution, and import.

2. The Consumer Protection Act, 2019 and the Consumer Protection (E-Commerce) Rules, 2020 

These are aimed at regulating e-commerce marketplaces to protect the interests of consumers. While Consumer Protection Act and these rules primarily target e-commerce platforms, they also have implications for the healthcare industry, especially for platforms selling fitness equipment and health supplements. Compliance with these rules is essential to ensure transparency, accuracy, and accountability in the sale of healthcare products online.

  • E-commerce platforms selling healthcare products such as fitness equipment and health supplements must ensure that all descriptions, images, and other content related to the products are accurate and correspond directly with their appearance, nature and other general features. 
  • For inventory e-commerce entities, that directly sell products to consumers, an accurate display of sale-related details such as return/exchange policies, payment methods, shipping information, etc., is mandatory. 
  • E-commerce platforms must ensure accuracy in advertisements, especially concerning healthcare products. Misleading or deceptive advertising can have serious consequences, particularly in the healthcare industry, where the efficacy and safety of products are paramount.
  • E-commerce platforms selling healthcare products must take measures to ensure the authenticity of the products as advertised. This includes verifying the quality, safety, and legitimacy of health supplements and fitness equipment sold on their platforms. 

3. The Clinical Establishments (Registration and Regulation) Act, 2010 

Compliance with The Clinical Establishments (Registration and Regulation) Act, 2010 is important for healthcare startups intending to establish healthcare facilities or clinics, as it sets standards for infrastructure, personnel, and services, thereby ensuring the quality and safety of patient care.

  • The act mandates the registration of clinical establishments, including hospitals, clinics, diagnostic centers, and laboratories. Healthcare startups planning to establish such establishments must undergo the registration process as per the provisions of the act.
  • The act aims to standardize the quality of healthcare services provided by clinical establishments. It sets forth norms and standards for infrastructure, equipment, personnel qualifications, and services offered.
  • The act prescribes standards for the infrastructure of clinical establishments, including facilities such as patient wards, operation theaters, and diagnostic equipment. 
  • Compliance with the Clinical Establishments Act is essential for ensuring quality assurance and patient safety.

4. The Telemedicine Practice Guidelines, 2020

These guidelines represents a pivotal regulatory framework governing remote medical consultations in India, particularly in the context of the surge in telemedicine spurred by the COVID-19 pandemic. For healthcare startups venturing into telemedicine, compliance with these guidelines is paramount to ensure regulatory adherence and maintain the quality, safety, and legality of their telemedicine services.

  • The guidelines outline the importance of obtaining informed consent from patients before initiating any teleconsultation. The healthcare industry must ensure that patients are adequately informed about the nature of telemedicine services, potential risks and benefits.
  • The guidelines provide clear directives regarding prescription norms in telemedicine. Healthcare industries offering teleconsultations must adhere to these norms, which include issuing electronic prescriptions with necessary details and ensuring compliance with relevant laws and regulations governing the prescription of medications remotely.
  • The guidelines lay down specific requirements for ensuring the confidentiality, integrity, and security of patient health information during virtual consultations.
  • Healthcare professionals offering telemedicine services are bound by professional codes of conduct and ethics. 
  • Compliance with the Telemedicine Practice Guidelines is essential for healthcare industries to operate legally and ethically in the telemedicine space.

5. The Information Technology Act, 2000 

Compliance with The Information Technology Act, 2000 is essential for healthcare industries handling sensitive patient information, as it mandates the implementation of robust data protection measures and ensures the confidentiality and integrity of patient data.

  • This act requires healthcare industries to implement robust data protection measures to safeguard patient data against unauthorized access, disclosure, or misuse.
  • The act emphasizes the importance of maintaining the confidentiality and privacy of patient data.
  • In the event of a data security breach involving patient information, healthcare industries are required to promptly notify affected individuals and regulatory authorities as per the provisions of the act.
  • The act governs the creation, storage, transmission, and access of Electronic Health Records (EHRs), imposing requirements for secure electronic storage, access controls, and data integrity verification.
  • The act also governs the retention and disposal of patient data, requiring healthcare industries to establish policies and procedures for the secure storage, retention, and eventual disposal of EHRs.

6. The Medical Device Rules, 2017 

These rules establish comprehensive regulatory compliance in healthcare governing the approval, import, manufacture, and distribution of medical devices in India. Compliance with these rules is essential for healthcare industries engaged in the development and marketing of medical devices to ensure regulatory approval, meet quality standards, and ensure patient safety. 

  • Healthcare industries must navigate this process diligently, submitting necessary documentation, conducting clinical trials if required, and obtaining approval from the Central Drugs Standard Control Organization (CDSCO) or other regulatory authorities before marketing their devices.
  • The rules prescribe quality standards and specifications for medical devices, including materials, design, manufacturing processes, and performance characteristics.
  • The rules govern the importation of medical devices into India, including registration requirements, labelling and packaging specifications, and import licensing procedures.
  • For medical devices manufactured in India, the rules specify manufacturing requirements, including facility registration, quality management systems, and compliance with Good Manufacturing Practices (GMP).
  • The rules also regulate the distribution and marketing of medical devices, including labelling, advertising and promotional activities.

7. National Medical Devices Policy, 2023 

This policy, aimed at accelerating the growth of the medical devices sector, emphasizes the importance of regulatory compliance to meet public health objectives such as access, affordability, quality, and innovation.

The policy recognizes the essential role of the medical devices sector in supporting healthcare infrastructure, especially evident during the COVID-19 pandemic. It underscores the need for a comprehensive framework to foster growth, innovation, and self-reliance in the sector, aligning with the government’s initiatives such as ‘Atmanirbhar Bharat’ and ‘Make in India.’

Key features of the National Medical Devices Policy, 2023 include:

  • The policy sets an ambitious vision to achieve a 10-12% share in the global medical device market over the next 25 years, aiming to increase the sector’s market size from $11 billion to $50 billion by 2030.
  • It outlines various missions focused on access, affordability, quality, patient-centred care, preventive health, research, innovation, and skilled manpower development to drive sectoral growth.
  • The policy proposes strategies across six broad areas, including regulatory streamlining, enabling infrastructure, R&D and innovation, attracting investments, human resources development, and brand positioning and awareness creation.
  • The policy aims to promote research and development through initiatives like establishing centres of excellence and innovation hubs and supporting start-ups to foster innovation in the sector.

Final Thoughts

Compliance in the healthcare industry is indispensable for safeguarding patient safety, maintaining quality care, and upholding legal and ethical standards. From the stringent requirements of the Drugs and Cosmetics Act to the intricate landscape of telemedicine guidelines and data protection regulations, healthcare businesses must navigate a complex framework of laws and standards to operate effectively. Non-compliance poses significant risks, including legal penalties and reputational damage.

Ensure Your Healthcare Business Meets Indian Regulatory Standards

Our team of legal experts possesses the knowledge and experience to guide your business through the intricacies of regulatory compliance in healthcare. From understanding the nuances of pharmaceutical regulations to ensuring data security in telemedicine practices, we are here to provide tailored solutions that meet your compliance needs. 

For healthcare businesses looking to set up operations in India or ensure ongoing compliance, Burgeon Law offers comprehensive services to streamline the process and mitigate risks. Visit our “Setting Up a Healthcare Business in India” service page to learn how we can help you establish a compliant and successful healthcare venture in India. 


1. What is regulatory compliance in the healthcare industry?

Regulatory compliance in the healthcare industry refers to the adherence to laws, regulations, standards, and guidelines set forth by governing bodies and regulatory authorities. This includes ensuring that healthcare practices, facilities, products, and services meet legal requirements, quality standards, and ethical principles to protect patient safety, privacy, and welfare.

2. What are the key regulations affecting healthcare businesses in India?

Key regulations affecting healthcare businesses in India include:

  • Drugs and Cosmetics Act, 1940
  • Clinical Establishments (Registration and Regulation) Act, 2010
  • Telemedicine Practice Guidelines, 2020
  • Consumer Protection Act, 2019
  • Medical Device Rules, 2017
  • Information Technology Act, 2000

3. How can healthcare businesses ensure compliance with safety regulations?

Healthcare businesses can ensure compliance with safety regulations by:

  • Regularly reviewing and understanding relevant safety regulations.
  • Implementing policies and procedures to meet regulatory requirements.
  • Providing training to staff on safety protocols and compliance measures.
  • Conducting regular inspections to identify and address safety issues.
  • Maintaining accurate documentation of safety practices and compliance efforts.

4. How can new healthcare businesses navigate regulatory requirements?

New healthcare businesses can navigate regulatory requirements by:

  • Conducting thorough research to understand applicable regulations.
  • Seeking guidance from legal experts specializing in healthcare law.
  • Developing a compliance plan tailored to the specific regulatory landscape.
  • Establishing clear policies and procedures to ensure adherence to regulations.
  • Regularly monitoring updates and changes in regulations and adjusting practices accordingly.

5. How often should healthcare businesses review their compliance policies?

Healthcare businesses should review their compliance policies regularly, ideally on an annual basis at a minimum. However, the frequency of reviews may vary depending on factors such as changes in regulations, organizational growth, and emerging risks. Additionally, reviews should be conducted whenever there are significant changes in operations that may impact compliance. 

6. What are the challenges of pharmaceutical compliance in healthcare?

Challenges of pharmaceutical compliance in healthcare include:

  • Evolving Regulations
  • Complex Supply Chains
  • Quality Assurance
  • Data Security
  • Global Market Access
  • Enforcement Actions
  • Rapid Technological Advances
  • Ethical Considerations

Explore More Resources


Contact Us

    burgeon law white logo


    As per the rules of the Bar Council of India, law firms are not permitted to solicit work and advertise.

    By clicking the “Agree” button and accessing the website, the visitor fully understands and accepts that the contents herein are solely for informational purposes and should not be interpreted as solicitation or advertisement. The firm is not liable, in any manner, for the consequences of any action taken by a visitor relying on materials/ information provided on the website. The firm urges visitors to seek independent legal advice for any legal issues.